Low periperal plasma renin activity as a marker in pediatric hypertension

Pediatric Nephrology

Volumn 11, Issue 3, 1997, Pages 343-346

  Yiu, Verna W Y ^a,d   Dluhy, Robert P ^b   Lifton, Richard P ^c   Guay Woodford, Lisa M ^a,e  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

^e University of Alabama at Birmingham   (United States)

Author keywords

Glucocorticoid remediable aldosteronism; Hypertension; Plasma renin activity

Indexed keywords

ANTIHYPERTENSIVE AGENT; RENIN; ALDOSTERONE SYNTHASE; BIOLOGICAL MARKER;

ARTICLE; CASE REPORT; FAMILY HISTORY; FEMALE; GENE DUPLICATION; GENETIC ANALYSIS; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; PATHOGENESIS; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT FAILURE; URINALYSIS; BIOSYNTHESIS; BLOOD; CHILD; GENETICS; MULTIGENE FAMILY;

ALDOSTERONE SYNTHASE; BIOLOGICAL MARKERS; CHILD; FEMALE; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; MULTIGENE FAMILY; RENIN;

EID: 0031154641     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004670050292     Document Type: Article

References (19)

1. Task Force on Blood Pressure Control in Children (1987) Report of the Second Task Force on Blood Pressure Control in Children - 1987. Pediatrics 79: 1 - 25
2. Lieberman E (1994) Pediatric hypertension: clinical perspective. Mayo Clin Proc 69: 1098 - 1107
3. Arar MY, Hogg RJ, Arant BS, Seikaly MG (1994) Etiology of sustained hypertension in children in the southwestern United States. Pediatr Nephrol 8: 186 - 189
4. Lieberman E (1994) Hypertension in childhood and adolescence. In: Kaplan NM (ed) Clinical hypertension, 6th edn. Williams and Wilkins, Baltimore, pp 437 - 462
5. Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, Lalouel MA (1992) Chimenc 11β-hydroxylase/aldosterone synthase gene causes GRA and human hypertension. Nature 355: 262 - 265
6. Rich G, Ulick S, Cook S, Wang J, Lifton RP, Dluhy RG (1992) GRA in a large kindred: clinical spectrum and diagnosis using a characteristic biochemical phenotype. Ann Intern Med 116: 813 - 820
7. Lifton RP, Dluhy RG, Powers M, Rich GM, Gutkin M, Fallo F, Gill JR, Feld L, Ganguly A, Laidlaw JC, Murnaghan DJ, Kaufman C, Stockigt JR, Ulick S, Lalouel MA (1992) Hereditary hypertension caused by chimeric gene duplications and ectopic expression of aldosterone synthetase. Nature Genet 2: 66 - 74
8. Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M, Gill JR, Ulick S, Milora RV, Findling JW, Canessa CM, Rossier BC, Lifton RP (1994) Liddle's syndrome: heritable human hypertension caused by mutations in the β subunit of the epithelial sodium channel. Cell 79: 407 - 414
9. Hansson JH, Nelson-Williams C, Suzuki H, Schild L, Shimkets R, Lu Y, Canessa C, Iwasaki T, Rossier B, Lifton RP (1995) Hypertension caused by a truncated epithelial sodium channel γ subunit: genetic heterogeneity of Liddle syndrome. Nature Genet 11: 76 - 82
10. Mune T, Rogerson FM, Nikkila H, Agarwal AK, White PC (1995) Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase. Nature Genet 10: 394 - 399
11. Dluhy RG, Feld L, Ahola SJ, Stern P, Rich GM, Ulick S, Lifton RP (1993) Clinical spectrum of GRA in children Pediatr Res 33: 127A
12. Harshfield GA, Alpert BS, Pulliam DA (1993) Renin-angiotension-aldosterone system in healthy subjects aged ten to eighteen years. J Pediatr 122: 563 - 567
13. Lifton RP (1995) Genetic determinants of human hypertension. Proc Natl Acad Sci USA 92. 8545 - 8551
14. Sutherland DJA, Ruse JL, Laidlaw JC (1966) Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. Can Med Assoc J 95: 1109 - 1119
15. Dluhy RG, Lifton RP (1995) Glucocorticoid-remediable aldosteronism (GRA): diagnosis, variability of phenotype and regulation of potassium homeostasis. Steroids 60: 48 - 51
16. Shackelton CH (1993) Mass spectrometry in the diagnosis of steroid-related disorders and in hypertension research. J Steroid Biochem Mol Biol 45: 127 - 140
17. Hoefnagels WHL, Kloppenborg PWC (1982) Hazards of long-term dexamethasone treatment in primary aldosteronism. N Engl J Med 306: 427 - 428
18. Botero-Velez M, Curtis J, Warnock D (1994) Brief report: Liddle's syndrome revisited. N Engl J Med 330: 178 - 181
19. Ulick S, Tedde R, Wang JZ (1992) Defective ring A reduction of cortisol as the major metabolic error in the syndrome of apparent mineralocorticoid excess. J Clin Endocrinol Metab 74: 593 - 599